HCP (HCP) : The total money flow in HCP (HCP) was negative ($0.93 million), which signals selling by the traders on Fridays session. They trimmed their holdings by selling the stock on downticks to the tune of $2.15 million. In comparison, the inflow of money into the stock on upticks was $1.23 million. The uptick to downtick ratio was 0.57. Similarly, the block trades show selling by large traders on strength. The value of stocks sold down on downtick was $0.79 million. The negative money flow of ($0.79 million) confirms the selling in HCP (HCP) on strength. HCP (HCP) gained $0.08 at $38.63, a gain of 0.21% over the previous days close. However, the stock registered 3.21% in the week.
HCP (HCP) : The highest short term price target forecast on HCP (HCP) is $43 and the lowest target price is $23. A total of 7 equity analysts are currently covering the company. The average price of all the analysts is $31.43 with a standard deviation of $6.29.
HCP (NYSE:HCP): stock turned positive on Friday. Though the stock opened at $38.46, the bulls momentum made the stock top out at $39 level for the day. The stock recorded a low of $38.38 and closed the trading day at $38.9, in the green by 0.91%. The total traded volume for the day was 2,622,250. The stock had closed at $38.55 in the previous days trading.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Executive Vice President) of Hcp, Inc., Hsiao Kai had sold 266 shares worth of $9,587 in a transaction dated May 9, 2016. In this transaction, 266 shares were sold at $36.04 per share.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.